CharlesA.LinkerMD
Oncology • San Francisco, CAHematologists at UCSF Medical Center Ambulatory Care Center
Are you Dr. Linker?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 40 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
400 Parnassus Ave
San Francisco, CA 94143Phone+1 415-353-2421Fax+1 415-353-2467
Summary
- Dr. Charles Linker, MD is an oncologist in San Francisco, California. He is currently licensed to practice medicine in California.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1977 - 1978- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1974 - 1976
Stanford University School of MedicineClass of 1974
Certifications & Licensure
CA State Medical License 1975 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia in Second Remission Start of enrollment: 1996 Jun 01
- Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed or Progressive B-Cell Diffuse Large Cell Lymphoma Start of enrollment: 2003 Mar 01
- Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia Start of enrollment: 2005 May 01
- Join now to see all
Publications & Presentations
PubMed
- 6 citationsLong-Term Follow-up of CALGB (Alliance) 100001: Autologous Followed by Nonmyeloablative Allogeneic Transplant for Multiple MyelomaSarah A. Holstein, Vera J. Suman, Kouros Owzar, Katelyn Santo, Don M. Benson
Biology of Blood and Marrow Transplantation. 2020-08-01 - 121 citationsUpdated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a...Sarah A. Holstein, Sin-Ho Jung, Paul G. Richardson, Craig C. Hofmeister, David D. Hurd
The Lancet. Haematology. 2017-09-01 - 85 citationsPhase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen:...Steven M. Devine, Kouros Owzar, William Blum, Flora Mulkey, Richard Stone
Journal of Clinical Oncology. 2015-12-10
